Clinical Trial Update: Radium-223 and Radiotherapy in Hormone-Naïve Men With Oligometastatic Prostate Cancer to Bone [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating radium-223 dichloride with radiotherapy in hormone-naïve men with oligometastatic prostate cancer to bone; results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer with Bone Metastases

Drugs mentioned

• Xofigo (radium-223 dichloride)

Snippet

Sponsor: University of Utah | Conditions: Prostate Cancer Metastatic to Bone | Phase 2 | Status: COMPLETED | Results posted: 2024-01-30